1. Home
  2. AFYA vs EVO Comparison

AFYA vs EVO Comparison

Compare AFYA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFYA
  • EVO
  • Stock Information
  • Founded
  • AFYA 1999
  • EVO 1993
  • Country
  • AFYA Brazil
  • EVO Germany
  • Employees
  • AFYA N/A
  • EVO N/A
  • Industry
  • AFYA Other Consumer Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AFYA Real Estate
  • EVO Health Care
  • Exchange
  • AFYA Nasdaq
  • EVO Nasdaq
  • Market Cap
  • AFYA 1.6B
  • EVO 1.6B
  • IPO Year
  • AFYA 2019
  • EVO 2021
  • Fundamental
  • Price
  • AFYA $15.50
  • EVO $4.44
  • Analyst Decision
  • AFYA Sell
  • EVO Buy
  • Analyst Count
  • AFYA 4
  • EVO 2
  • Target Price
  • AFYA $19.38
  • EVO $5.90
  • AVG Volume (30 Days)
  • AFYA 121.6K
  • EVO 238.2K
  • Earning Date
  • AFYA 11-13-2024
  • EVO 11-06-2024
  • Dividend Yield
  • AFYA N/A
  • EVO N/A
  • EPS Growth
  • AFYA 62.61
  • EVO N/A
  • EPS
  • AFYA 1.17
  • EVO N/A
  • Revenue
  • AFYA $584,951,886.00
  • EVO $866,665,179.00
  • Revenue This Year
  • AFYA $16.83
  • EVO $4.56
  • Revenue Next Year
  • AFYA $11.70
  • EVO $13.44
  • P/E Ratio
  • AFYA $13.24
  • EVO N/A
  • Revenue Growth
  • AFYA 16.67
  • EVO N/A
  • 52 Week Low
  • AFYA $14.52
  • EVO $2.85
  • 52 Week High
  • AFYA $22.48
  • EVO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • AFYA 43.26
  • EVO 45.00
  • Support Level
  • AFYA $14.52
  • EVO $4.39
  • Resistance Level
  • AFYA $16.21
  • EVO $4.81
  • Average True Range (ATR)
  • AFYA 0.50
  • EVO 0.14
  • MACD
  • AFYA -0.07
  • EVO -0.07
  • Stochastic Oscillator
  • AFYA 44.95
  • EVO 0.00

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: